Jacques Galipeau, MD obtained his Medical Degree from the University of Montreal and completed specialty training in internal medicine at McGill University. He went on to the Tufts-affiliated New England Medical Center in Boston for three years of subspecialty training in Hematology & Medical Oncology followed by a two-year scientific fellowship in gene therapy at St-Jude Children’s research hospital in Memphis, Tennessee. Dr. Galipeau served as Hematology and Oncology Faculty at McGill University (1997-2009) and Tenured Professor and Georgia Cancer Coalition Distinguished Cancer Scholar at Emory University (2009-2016). Since 2016, he has been the Don and Marilyn Anderson Tenured Professor of Oncology within the Department of Medicine and UW Carbone Comprehensive Cancer Center at the University of Wisconsin in Madison and was appointed the inaugural Associate Dean for Therapeutics Development at the UW School of Medicine and Public Health. Dr Galipeau is President (2022-2024) of the International Society of Cell Therapy.